Vincerx Pharma (VINC) Short Interest Ratio & Short Volume $0.04 +0.00 (+0.95%) As of 05/21/2025 03:45 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vincerx Pharma Short Interest DataVincerx Pharma (VINC) has a short interest of 133,300 shares, representing 2.97% of the float (the number of shares available for trading by the public). This marks a -2.84% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 427,502 shares to cover all short positions.Current Short Interest133,300 sharesPrevious Short Interest137,200 sharesChange Vs. Previous Month-2.84%Dollar Volume Sold Short$36,657.50Short Interest Ratio0.1 Days to CoverLast Record DateApril 15, 2025Outstanding Shares5,234,000 sharesFloat Size4,490,000 sharesShort Percent of Float2.97%Today's Trading Volume128,106 sharesAverage Trading Volume427,502 sharesToday's Volume Vs. Average30% Short Selling Vincerx Pharma? Sign up to receive the latest short interest report for Vincerx Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVINC Short Interest Over TimeVINC Days to Cover Over TimeVINC Percentage of Float Shorted Over Time Vincerx Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025133,300 shares $36,657.50 -2.8%3.0%0.1 $0.28 3/31/2025137,200 shares $72,633.68 +99.4%3.1%0.1 $0.53 3/15/202568,800 shares $56,608.64 -64.2%3.6%0.1 $0.82 2/28/2025191,900 shares $209,171.00 +76.9%10.0%0.2 $1.09 2/15/2025108,500 shares $141,050.00 -59.7%5.7%0.2 $1.30 1/31/2025269,200 shares $425,336.00 +383.3%14.6%0.4 $1.58 1/15/202555,700 shares $170,107.80 -98.8%N/A0 $3.05 12/31/20244,710,000 shares $1.24 million +1,022.5%N/A0.7 $0.26 12/15/2024419,600 shares $80,143.60 -42.9%N/A0.6 $0.19 11/30/2024735,400 shares $209,589.00 +22.6%N/A1.2 $0.29 Get the Latest News and Ratings for VINC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vincerx Pharma and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024600,000 shares $177,000.00 -26.3%N/A1.1 $0.30 10/31/2024813,800 shares $284,016.20 -2.8%N/A1.6 $0.35 10/15/2024837,300 shares $318,090.27 +189.4%N/A1.8 $0.38 9/30/2024289,300 shares $207,138.80 -28.2%N/A0.7 $0.72 9/15/2024403,000 shares $283,832.90 +1.4%N/A2.2 $0.70 8/31/2024397,500 shares $325,950.00 -1.7%N/A2.1 $0.82 8/15/2024404,200 shares $242,115.80 +7.0%N/A2.1 $0.60 7/31/2024377,900 shares $240,873.46 -6.2%N/A2 $0.64 7/15/2024403,000 shares $281,414.90 -31.7%N/A1.5 $0.70 6/30/2024590,000 shares $477,900.00 +36.2%N/A0.9 $0.81 6/15/2024433,200 shares $294,316.08 -29.3%N/A0.6 $0.68 5/31/2024612,500 shares $386,487.50 +7.9%N/A0.8 $0.63 5/15/2024567,500 shares $424,433.25 -44.9%N/A0.6 $0.75 4/30/20241,030,000 shares $851,810.00 -14.2%6.0%0.9 $0.83 4/15/20241,200,000 shares $1.04 million +50.0%8.9%1.1 $0.87 3/31/2024799,900 shares $4.05 million -7.4%5.9%0.6 $5.06 3/15/2024863,700 shares $4.82 million +95.2%6.4%0.8 $5.58 2/29/2024442,400 shares $1.66 million +83.3%3.3%0.5 $3.75 2/15/2024241,400 shares $415,208.00 -29.9%1.8%0.3 $1.72 1/31/2024344,200 shares $450,902.00 -32.8%2.6%0.7 $1.31 1/15/2024512,500 shares $702,125.00 +375.9%3.8%1.1 $1.37 12/31/2023107,700 shares $127,086.00 -12.6%0.8%0.2 $1.18 12/15/2023123,200 shares $77,739.20 -20.1%0.9%1.8 $0.63 11/30/2023154,200 shares $100,230.00 +19.8%1.2%3 $0.65 11/15/2023128,700 shares $99,871.20 -1.3%1.0%2.4 $0.78 10/31/2023130,400 shares $120,567.84 -10.6%1.0%1.6 $0.92 10/15/2023145,800 shares $141,426.00 -13.7%1.1%1.2 $0.97 9/30/2023168,900 shares $170,589.00 -3.7%1.3%1.4 $1.01 9/15/2023175,400 shares $154,352.00 -11.8%1.3%1.3 $0.88 8/31/2023198,900 shares $131,274.00 +87.8%1.5%1.5 $0.66Warning: Prepare to Be Shocked by These Payouts (Ad)There's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don't even pay dividends. It's fast, it's legal, and most people have no clue it exists.Click here to see how much you could be collecting each month → 8/15/2023105,900 shares $91,074.00 -18.5%0.8%0.8 $0.86 7/31/2023129,900 shares $140,292.00 +8.3%1.0%1.2 $1.08 7/15/2023120,000 shares $150,000.00 -76.7%0.9%1.3 $1.25 6/30/2023514,100 shares $668,330.00 -18.6%4.0%5.8 $1.30 6/15/2023631,300 shares $965,889.00 +5.4%4.9%8.1 $1.53 5/31/2023599,200 shares $1.11 million -3.1%4.6%8.5 $1.85 5/15/2023618,300 shares $989,280.00 +1.9%4.4%10.3 $1.60 4/30/2023607,000 shares $795,170.00 +3.7%4.3%10.5 $1.31 4/15/2023585,200 shares $575,134.56 +0.7%4.1%10 $0.98 3/31/2023581,100 shares $604,344.00 +0.6%4.1%10.1 $1.04 3/15/2023577,700 shares $549,392.70 -0.4%3.5%7.9 $0.95 2/28/2023580,000 shares $672,800.00 +0.8%3.6%3 $1.16 2/15/2023575,500 shares $673,335.00 -1.2%3.6%2.8 $1.17 1/31/2023582,300 shares $879,273.00 -1.6%3.6%2.5 $1.51 1/15/2023591,900 shares $627,414.00 -12.8%3.6%2.6 $1.06 12/30/2022678,700 shares $692,274.00 -31.4%4.2%2.8 $1.02 12/15/2022989,200 shares $797,493.04 +59.4%6.1%4.1 $0.81 11/30/2022620,500 shares $434,350.00 -6.5%3.8%5.1 $0.70 11/15/2022663,900 shares $542,273.52 +0.6%4.1%6 $0.82 10/31/2022660,100 shares $706,307.00 +6.2%4.0%6.2 $1.07 10/15/2022621,700 shares $714,955.00 -60.4%3.8%6.1 $1.15 9/30/20221,570,000 shares $2.17 million +2.6%9.6%18 $1.38 9/15/20221,530,000 shares $2.20 million No Change9.3%10.6 $1.44 8/31/20221,530,000 shares $2.33 million -3.2%9.4%8.3 $1.52 8/15/20221,580,000 shares $2.58 million +1.9%9.7%8.3 $1.63 7/31/20221,550,000 shares $2.17 million +0.7%9.5%9 $1.40 7/15/20221,540,000 shares $2.25 million -4.4%9.5%8.9 $1.46 6/30/20221,610,000 shares $2.13 million -10.6%11.0%9.4 $1.32 6/15/20221,800,000 shares $2.65 million +1.1%12.2%11.1 $1.47 5/31/20221,780,000 shares $2.90 million +0.6%12.1%20.3 $1.63 5/15/20221,770,000 shares $3.81 million +0.6%N/A21.3 $2.15 4/30/20221,760,000 shares $4.54 million +2.9%N/A20.8 $2.58 4/15/20221,710,000 shares $4.94 million +7.6%N/A16.1 $2.89 3/31/20221,590,000 shares $6.36 million +13.6%N/A12.7 $4.00 3/15/20221,400,000 shares $5.71 million +6.9%N/A11.5 $4.08 2/28/20221,310,000 shares $6.64 million +1.6%N/A10.4 $5.07 2/15/20221,290,000 shares $8.48 million +13.2%8.8%10.3 $6.57 1/31/20221,140,000 shares $8.20 million +24.6%8.0%9.4 $7.19 1/15/2022915,000 shares $7.32 million +10.1%6.2%9.8 $8.00 12/31/2021831,100 shares $8.47 million +13.1%5.7%11.4 $10.19 12/15/2021734,800 shares $7.62 million +0.7%5.0%9.4 $10.37 11/30/2021729,700 shares $7.65 million -6.6%5.0%7.7 $10.49 11/15/2021781,300 shares $9.77 million +1.9%5.3%7.1 $12.50 10/29/2021766,600 shares $10.71 million -3.4%5.7%6.3 $13.97 10/15/2021793,500 shares $11.78 million -36.0%7.1%5.9 $14.85 9/30/20211,240,000 shares $20.05 million +12.7%11.1%8.7 $16.17 9/15/20211,100,000 shares $17.40 million -5.2%9.8%6.4 $15.82 8/31/20211,160,000 shares $18.19 million +63.9%10.3%7 $15.68 8/13/2021707,700 shares $9.17 million -2.6%6.3%4.6 $12.96 7/30/2021726,200 shares $9.62 million -3.0%6.5%4.8 $13.25Warning: Prepare to Be Shocked by These Payouts (Ad)There's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don't even pay dividends. It's fast, it's legal, and most people have no clue it exists.Click here to see how much you could be collecting each month → 7/15/2021748,700 shares $10.80 million -1.7%6.7%5.3 $14.42 6/30/2021761,900 shares $9.90 million +65.5%6.8%5.6 $12.99 6/15/2021460,500 shares $5.73 million -6.2%4.1%4.7 $12.44 5/28/2021490,700 shares $6.81 million +2.9%3.0%5.1 $13.88 5/14/2021477,000 shares $7.79 million -12.1%3.0%4.8 $16.34 4/30/2021542,800 shares $8.96 million -6.5%3.3%5.3 $16.50 4/15/2021580,500 shares $11.06 million -6.7%4.5%6.1 $19.05 3/31/2021622,000 shares $12.02 million +13.0%4.8%6.3 $19.33 3/15/2021550,500 shares $12.37 million +17.5%4.2%5.6 $22.47 2/26/2021468,700 shares $8.86 million -16.4%3.6%6.5 $18.90 2/12/2021560,400 shares $9.52 million +66.3%4.3%10.2 $16.98 1/29/2021337,000 shares $6.26 million +317.6%2.7%8.8 $18.57 1/15/202180,700 shares $1.63 million No Change0.7%2.4 $20.20 VINC Short Interest - Frequently Asked Questions What is Vincerx Pharma's current short interest? Short interest is the volume of Vincerx Pharma shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 133,300 shares of VINC short. 2.97% of Vincerx Pharma's shares are currently sold short. Learn More on Vincerx Pharma's current short interest. What is a good short interest percentage for Vincerx Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.97% of Vincerx Pharma's floating shares are currently sold short. Is Vincerx Pharma's short interest increasing or decreasing? Vincerx Pharma saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 133,300 shares, a decline of 2.8% from the previous total of 137,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vincerx Pharma's float size? Vincerx Pharma currently has issued a total of 5,234,000 shares. Some of Vincerx Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vincerx Pharma currently has a public float of 4,490,000 shares. How does Vincerx Pharma's short interest compare to its competitors? 2.97% of Vincerx Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Vincerx Pharma: Viracta Therapeutics, Inc. (0.66%), Avenue Therapeutics, Inc. (2.95%), Biora Therapeutics, Inc. (6.64%), Virpax Pharmaceuticals, Inc. (26.21%), TFF Pharmaceuticals, Inc. (3.95%), TC Biopharm (Holdings) Plc (176.43%), Petros Pharmaceuticals, Inc. (28.22%), NuCana plc (11.26%), Aditxt, Inc. (78.95%), and Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Vincerx Pharma stock? Short selling VINC is an investing strategy that aims to generate trading profit from Vincerx Pharma as its price is falling. VINC shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vincerx Pharma? A short squeeze for Vincerx Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VINC, which in turn drives the price of the stock up even further. How often is Vincerx Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VINC, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Viracta Therapeutics Short Squeeze Avenue Therapeutics Short Squeeze Biora Therapeutics Short Squeeze Virpax Pharmaceuticals Short Squeeze TFF Pharmaceuticals Short Squeeze TC Biopharm Short Squeeze Petros Pharmaceuticals Short Squeeze NuCana Short Squeeze Aditxt Short Squeeze Alvotech Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VINC) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vincerx Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vincerx Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VINC Stock Free VINC Stock Alerts